| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 145, 80-85, Copyright © 1994 by American Society for Investigative Pathology
REGULAR ARTICLES |
ES Yi, S Yin, DL Harclerode, A Bedoya, NB Bikhazi, RM Housley, SL Aukerman, CF Morris, GF Pierce and TR Ulich
Department of Pathology, University of California, San Diego School of Medicine.
Keratinocyte growth factor (KGF) causes a proliferation of pancreatic ductal epithelial cells in adult rats after daily systemic administration for 1 to 2 weeks. Even before the proliferation of intralobular ducts is histologically evident, KGF also induces proliferating cell nuclear antigen expression within the ductal epithelium of intercalated, intralobular, and interlobular ducts. KGF also causes incorporation of 5-bromodeoxyuridine in ductal epithelial cells. Epithelial cell proliferation is histologically most prominent at the level of the intralobular ducts adjacent to and within the islets of Langerhans. Pancreatic ductal proliferation is not histologically apparent in rats sacrificed 7 to 10 days after the cessation of KGF administration. The pancreatic hormones insulin, glucagon, somatostatin, and pancreatic polypeptide are normally distributed within islets that demonstrate intrainsular ductal proliferation. The proliferating ductal epithelium does not show endocrine differentiation as evidenced by the lack of immunoreactivity for pancreatic hormones. KGF is a potent in vivo mitogen for pancreatic ductal epithelial cells.
This article has been cited by other articles:
 |
|
 |
|
  J. Movassat and B. Portha Early administration of keratinocyte growth factor improves {beta}-cell regeneration in rat with streptozotocin-induced diabetes J. Endocrinol., November 1, 2007; 195(2): 333 - 340. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Cho, T. Ishiwata, E. Uchida, N. Nakazawa, M. Korc, Z. Naito, and T. Tajiri Enhanced Expression of Keratinocyte Growth Factor and Its Receptor Correlates with Venous Invasion in Pancreatic Cancer Am. J. Pathol., June 1, 2007; 170(6): 1964 - 1974. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. W. Finch and J. S. Rubin Keratinocyte growth factor expression and activity in cancer: implications for use in patients with solid tumors. J Natl Cancer Inst, June 21, 2006; 98(12): 812 - 824. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Ulrich, M. Stern, M. E. Goddard, J. Williams, J. Zhu, A. Dewar, H. A. Painter, P. K. Jeffery, D. R. Gill, S. C. Hyde, et al. Keratinocyte growth factor therapy in murine oleic acid-induced acute lung injury Am J Physiol Lung Cell Mol Physiol, June 1, 2005; 288(6): L1179 - L1192. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. J. Meropol, R. A. Somer, J. Gutheil, R. J. Pelley, M. R. Modiano, E. K. Rowinsky, M. L. Rothenberg, S. W. Redding, C. M. Serdar, B. Yao, et al. Randomized Phase I Trial of Recombinant Human Keratinocyte Growth Factor Plus Chemotherapy: Potential Role as Mucosal Protectant J. Clin. Oncol., April 15, 2003; 21(8): 1452 - 1458. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. L Fowden and D. J Hill Intra-uterine programming of the endocrine pancreas Br. Med. Bull., November 1, 2001; 60(1): 123 - 142. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Tyrberg, J. Ustinov, T. Otonkoski, and A. Andersson Stimulated Endocrine Cell Proliferation and Differentiation in Transplanted Human Pancreatic Islets: Effects of the ob Gene and Compensatory Growth of the Implantation Organ Diabetes, February 1, 2001; 50(2): 301 - 307. [Abstract] [Full Text]
|
|
|
|
 |
|
 C. R. Scoggins, I. M. Meszoely, M. Wada, A. L. Means, L. Yang, and S. D. Leach p53-Dependent acinar cell apoptosis triggers epithelial proliferation in duct-ligated murine pancreas Am J Physiol Gastrointest Liver Physiol, October 1, 2000; 279(4): G827 - G836. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Bonner-Weir, M. Taneja, G. C. Weir, K. Tatarkiewicz, K.-H. Song, A. Sharma, and J. J. O'Neil In vitro cultivation of human islets from expanded ductal tissue PNAS, July 5, 2000; 97(14): 7999 - 8004. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. L. Krakowski, M. R. Kritzik, E. M. Jones, T. Krahl, J. Lee, M. Arnush, D. Gu, and N. Sarvetnick Pancreatic Expression of Keratinocyte Growth Factor Leads to Differentiation of Islet Hepatocytes and Proliferation of Duct Cells Am. J. Pathol., March 1, 1999; 154(3): 683 - 691. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. M. Danilenko Preclinical and Early Clinical Development of Keratinocyte Growth Factor, an Epithelial- Specific Tissue Growth Factor Toxicol Pathol, January 1, 1999; 27(1): 64 - 71. [Abstract] [PDF]
|
|
|
|
 |
|
 A. Panoskaltsis-Mortari, D. L. Lacey, D. A. Vallera, and B. R. Blazar Keratinocyte Growth Factor Administered Before Conditioning Ameliorates Graft-Versus-Host Disease After Allogeneic Bone Marrow Transplantation in Mice Blood, November 15, 1998; 92(10): 3960 - 3967. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Guo, E. S. Yi, A. M. Havill, I. Sarosi, L. Whitcomb, S. Yin, S. C. Middleton, P. Piguet, and T. R. Ulich Intravenous keratinocyte growth factor protects against experimental pulmonary injury Am J Physiol Lung Cell Mol Physiol, October 1, 1998; 275(4): L800 - L805. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Ishiwata, H. Friess, M. W. Buchler, M. E. Lopez, and M. Korc Characterization of Keratinocyte Growth Factor and Receptor Expression in Human Pancreatic Cancer Am. J. Pathol., July 1, 1998; 153(1): 213 - 222. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L Guo, L Degenstein, and E Fuchs Keratinocyte growth factor is required for hair development but not for wound healing. Genes & Dev., January 15, 1996; 10(2): 165 - 175. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
